Literature DB >> 8820403

The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth.

B Schieffer1, K E Bernstein, M B Marrero.   

Abstract

Most cell types, including vascular smooth muscle cells and rat kidney mesangial cells, are controlled mainly by two types of cell surface receptors: (a) single membrane-spanning tyrosine kinase receptors for growth factors and (b) seven-transmembrane G-protein linked receptors for vasoactive peptides such as angiotensin II, vasopressin, and endothelin. These vasoactive peptide hormones also act as growth factors in normal and abnormal cell development. However, in contrast to the growth factor receptors (e.g., epidermal growth factor receptor and platelet-derived growth factor receptor), the G-protein linked receptors, such as the angiotensin II AT1 receptor, lack cytoplasmic tyrosine kinase domains. Nevertheless, angiotensin II has recently been demonstrated to cause increased tyrosine phosphorylation of numerous proteins in several cellular systems. For example, angiotensin II has been reported to induce the tyrosine phosphorylation of the gamma-isoform of phospholipase C, pp120, pp125FAK, and members of the janus kinase/signal transducer and activator of transcription pathway. Furthermore, angiotensin II seems to modulate the activity of the soluble cytoplasmic tyrosine kinase pp60c-src, and this tyrosine kinase has been implicated in the phosphorylation of some of the above proteins. Understanding the biochemistry of tyrosine phosphorylation involved in G-protein coupled receptors, such as the AT1 receptor, may therefore lead to the development of new pharmacological interventions important in cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8820403     DOI: 10.1007/bf00196783

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  55 in total

1.  Focal adhesion kinase: an integrin-linked protein tyrosine kinase.

Authors:  M D Schaller; J T Parsons
Journal:  Trends Cell Biol       Date:  1993-08       Impact factor: 20.808

Review 2.  Nonpeptide angiotensin II receptor antagonists.

Authors:  P B Timmermans; P C Wong; A T Chiu; W F Herblin
Journal:  Trends Pharmacol Sci       Date:  1991-02       Impact factor: 14.819

3.  Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation.

Authors:  M B Taubman; B C Berk; S Izumo; T Tsuda; R W Alexander; B Nadal-Ginard
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

Review 4.  Inositol trisphosphate and diacylglycerol: two interacting second messengers.

Authors:  M J Berridge
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor.

Authors:  M B Marrero; B Schieffer; W G Paxton; L Heerdt; B C Berk; P Delafontaine; K E Bernstein
Journal:  Nature       Date:  1995-05-18       Impact factor: 49.962

6.  ANG II-induced tyrosine phosphorylation stimulates phospholipase C-gamma 1 and Cl-channels in mesangial cells.

Authors:  M B Marrero; B Schieffer; H Ma; K E Bernstein; B N Ling
Journal:  Am J Physiol       Date:  1996-06

7.  Vasopressin dependent tyrosine phosphorylation of a 38 kDa protein in human platelets.

Authors:  Y Granot; V Van Putten; R W Schrier
Journal:  Biochem Biophys Res Commun       Date:  1990-04-30       Impact factor: 3.575

Review 8.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

9.  Angiotensin II induces 3CH134, a protein-tyrosine phosphatase, in vascular smooth muscle cells.

Authors:  J L Duff; M B Marrero; W G Paxton; C H Charles; L F Lau; K E Bernstein; B C Berk
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

10.  Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma 1 in vascular smooth muscle cells.

Authors:  M B Marrero; W G Paxton; J L Duff; B C Berk; K E Bernstein
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

View more
  5 in total

Review 1.  Knockout of renin-angiotensin system genes: effects on vascular development.

Authors:  D Methot; T L Reudelhuber
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

2.  Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima formation following injury in mice.

Authors:  Annet Kirabo; S Paul Oh; Hideko Kasahara; Kay-Uwe Wagner; Peter P Sayeski
Journal:  J Mol Cell Cardiol       Date:  2011-03-17       Impact factor: 5.000

Review 3.  Angiotensin II type 1 receptor-modulated signaling pathways in neurons.

Authors:  E M Richards; M K Raizada; C H Gelband; C Sumners
Journal:  Mol Neurobiol       Date:  1999-02       Impact factor: 5.590

4.  Src homology 2-containing phosphotyrosine phosphatase regulates endothelin-1-induced epidermal growth factor receptor transactivation in rat renal tubular cell NRK-52E.

Authors:  Chen Cheng-Hsien; Hsu Yung-Ho; Sue Yuh-Mou; Hou Chun-Cheng; Lee Horng-Mo; Huang Huei-Mei; Chen Tso-Hsiao
Journal:  Pflugers Arch       Date:  2005-10-28       Impact factor: 3.657

Review 5.  Left ventricular remodelling in chronic primary mitral regurgitation: implications for medical therapy.

Authors:  Keir McCutcheon; Pravin Manga
Journal:  Cardiovasc J Afr       Date:  2018 Jan/Feb       Impact factor: 1.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.